Loading…
ABH Healthcare (ABH)₹40.30−2.07%Hospital
For the year to Mar 2026, sales were ₹51.71 Cr and net profit ₹5.65 Cr.
Company filings, consolidated accounts
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 3.51 | 29.23 | 40.01 | 48.62 | 51.71 |
| Expenses | 3.26 | 25.13 | 32.27 | 35.37 | 36.74 |
| Operating Profit | 0.22 | 4.06 | 7.63 | 13.18 | 14.82 |
| OPM % | 6.6% | 14.0% | 19.2% | 27.2% | 28.8% |
| Other Income | 0.00 | −0.01 | −0.72 | 0.04 | −0.03 |
| Interest | 0.05 | 1.34 | 2.97 | 3.72 | 4.49 |
| Depreciation | 0.08 | 1.57 | 1.75 | 2.11 | 2.40 |
| Profit before tax | 0.13 | 1.17 | 2.22 | 7.45 | 7.95 |
| Tax % | 33.3% | 37.9% | 24.9% | 28.0% | 28.9% |
| Exceptional items | 0.00 | −0.02 | −0.48 | 0.00 | −0.10 |
| Net Profit | 0.10 | 0.72 | 1.67 | 5.36 | 5.65 |
| EPS (Rs) | 8.98 | 3.54 | 8.28 | 26.62 | 7.04 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.11 | 2.01 | 2.01 | 2.01 | 8.00 |
| Reserves | 0.10 | 2.71 | 4.34 | 9.69 | 9.34 |
| Borrowings | 20.63 | 20.98 | 35.82 | 41.91 | 55.01 |
| Other Liabilities | 5.47 | 7.25 | 9.21 | 10.28 | 12.84 |
| Total Liabilities | 26.31 | 32.95 | 51.38 | 63.89 | 85.19 |
| Fixed Assets | 23.53 | 22.76 | 33.89 | 36.75 | 41.96 |
| CWIP | 0.00 | 0.62 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.13 | 0.30 | 1.75 |
| Other Assets | 2.78 | 9.57 | 17.36 | 26.84 | 41.48 |
| Inventories | 2.02 | 2.27 | 2.90 | 4.47 | 3.26 |
| Trade receivables | 0.24 | 5.90 | 11.99 | 19.76 | 33.13 |
| Cash & equivalents | 0.21 | 0.14 | 0.01 | 0.60 | 3.02 |
| Total Assets | 26.31 | 32.95 | 51.38 | 63.89 | 85.19 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 3.05 | −1.54 | 0.90 | 3.55 | 2.10 |
| Cash from investing activity | −23.52 | −1.44 | −13.05 | −4.52 | −9.12 |
| Cash from financing activity | 20.68 | 2.93 | 12.02 | 1.57 | 9.44 |
| Net cash flow | 0.23 | −0.07 | −0.15 | 0.60 | 2.43 |
| Capex | 23.45 | 1.03 | 14.10 | 4.63 | 8.24 |
| Free cash flow | −20.56 | −3.01 | −12.10 | −1.12 | −5.67 |
| CFO / OP % | 1,330.0% | −17.0% | 26.0% | 31.0% | 24.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 23 | 73 | 109 | 147 | 233 |
| Inventory days | — | — | — | 159 | 117 |
| Days payable | — | — | — | 242 | 239 |
| Cash conversion cycle | 25 | 75 | 111 | 67 | 114 |
| Working capital days | −984 | −58 | −16 | 37 | 173 |
| ROCE % | — | 10.8% | 17.4% | 23.3% | 19.9% |
ABH Healthcare's sales for the year to Mar 2026 were ₹51.71 Cr.
Net profit for the year to Mar 2026 was ₹5.65 Cr. Earnings per share over the same trailing period were ₹7.04.
ABH Healthcare reported borrowings of ₹55.01 Cr at Mar 2026, against cash and equivalents of ₹3.02 Cr.
Cash from operations was ₹2.10 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹5.67 Cr.